Literature DB >> 16988447

Delivery of DNA vaccines using electroporation.

Shawn Babiuk1, Sylvia van Drunen Littel-van den Hurk, Lorne A Babiuk.   

Abstract

Although DNA immunization remains a very attractive method to induce immunity to a variety of pathogens, the transfection efficiency is still relatively low. This is especially true in species other than mice. One way of improving this efficiency is to temporarily permeabilize the cells to allow cellular uptake of DNA plasmids. One way to permeabilize cells is by electroporation. The current report describes some of the parameters for optimizing electroporation for enhancing the level of gene expression. A clear concern is balancing the plasmid uptake with cellular or tissue damage. Techniques are described to achieve this goal.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988447     DOI: 10.1385/1-59745-168-1:73

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  6 in total

1.  SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12.

Authors:  Ross W Lindsay; Ian Ouellette; Heather E Arendt; Jennifer Martinez; Joanne DeStefano; Mary Lopez; George N Pavlakis; Maria J Chiuchiolo; Christopher L Parks; C Richter King
Journal:  Vaccine       Date:  2013-08-14       Impact factor: 3.641

Review 2.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

3.  DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice.

Authors:  H Davtyan; M Mkrtichyan; N Movsesyan; I Petrushina; G Mamikonyan; D H Cribbs; M G Agadjanyan; A Ghochikyan
Journal:  Gene Ther       Date:  2009-10-29       Impact factor: 5.250

4.  A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.

Authors:  David F Gardiner; Talia Rosenberg; Jerry Zaharatos; David Franco; David D Ho
Journal:  Vaccine       Date:  2009-04-09       Impact factor: 3.641

5.  The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses.

Authors:  Kenneth Bagley; Rong Xu; Ayuko Ota-Setlik; Michael Egan; Jennifer Schwartz; Timothy Fouts
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 6.  Inflammasomes in antiviral immunity: clues for influenza vaccine development.

Authors:  Tatsuya Yamazaki; Takeshi Ichinohe
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.